References
Al-Asmakh, M., and Zadjali, F. (2015). Use of germ-free animal models in microbiota-related research. J Microbiol Biotech 25, 1583–1588.
Brehm, M.A., Cuthbert, A., Yang, C., Miller, D.M., DiIorio, P., Laning, J., Burzenski, L., Gott, B., Foreman, O., Kavirayani, A., et al. (2010). Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rγnull mutation. Clin Immunol 135, 84–98.
Couzin-Frankel, J. (2013). Cancer immunotherapy. Science 342, 1432–1433.
De La Rochere, P., Guil-Luna, S., Decaudin, D., Azar, G., Sidhu, S.S., and Piaggio, E. (2018). Humanized mice for the study of immuno-oncology. Trends Immunol 39, 748–763.
Finger, L.R., Pu, J., Wasserman, R., Vibhakar, R., Louie, E., Hardy, R.R., Burrows, P.D., and Billips, L.G. (1997). The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene 197, 177–187.
Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., et al. (2018). Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97–103.
Gülden, E., Vudattu, N.K., Deng, S., Preston-Hurlburt, P., Mamula, M., Reed, J.C., Mohandas, S., Herold, B.C., Torres, R., Vieira, S.M., et al. (2017). Microbiota control immune regulation in humanized mice. JCI Insight 2.
Jin, Y., Dong, H., Xia, L., Yang, Y., Zhu, Y., Shen, Y., Zheng, H., Yao, C., Wang, Y., and Lu, S. (2019). The diversity of gut microbiome is associated with favorable responses to anti-programmed death 1 immunotherapy in Chinese patients with NSCLC. J Thorac Oncol 14, 1378–1389.
Li, J., Wang, J., and Wei, H. (2020). Strengthening the functional research on the interaction between host genes and microbiota. Sci China Life Sci 63, 929–932.
Li, J., and Wei, H. (2019). Establishment of an efficient germ-free animal system to support functional microbiome research. Sci China Life Sci 62, 1400–1403.
Lute, K.D., May Jr, K.F., Lu, P., Zhang, H., Kocak, E., Mosinger, B., Wolford, C., Phillips, G., Caligiuri, M.A., Zheng, P., et al. (2005). Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies. Blood 106, 3127–3133.
Mestas, J., and Hughes, C.C.W. (2004). Of mice and not men: differences between mouse and human immunology. J Immunol 172, 2731–2738.
Nguyen, T.L.A., Vieira-Silva, S., Liston, A., and Raes, J. (2015). How informative is the mouse for human gut microbiota research? Dis Model Mech 8, 1–16.
Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M.P., et al. (2018). Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97.
Sambi, M., Bagheri, L., and Szewczuk, M.R. (2019). Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates. J Oncol 2019, 1–12.
Sanmamed, M.F., Chester, C., Melero, I., and Kohrt, H. (2016). Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies. Ann Oncol 27, 1190–1198.
Skelly, A.N., Sato, Y., Kearney, S., and Honda, K. (2019). Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol 19, 305–323.
Turnbaugh, P.J., Ridaura, V.K., Faith, J.J., Rey, F.E., Knight, R., and Gordon, J.I. (2009). The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1, 6ra14.
Zhao, Y., Shuen, T.W.H., Toh, T.B., Chan, X.Y., Liu, M., Tan, S.Y., Fan, Y., Yang, H., Lyer, S.G., Bonney, G.K., et al. (2018). Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut 67, 1845–1854.
Zheng, P., Zeng, B., Liu, M., Chen, J., Pan, J., Han, Y., Liu, Y., Cheng, K., Zhou, C., Wang, H., et al. (2019). The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv 5, eaau8317.
Acknowledgements
This work was supported by grants from the National Key Research and Development Program of China (2017YFD0500503 and 2017YFD0501000), the National Natural Science Foundation of China (81770434 and 81370906), and the National Program on Key Basic Research Project of China (973 Program) (2007CB513007 and 2013CB531406).
Author information
Authors and Affiliations
Corresponding author
Additional information
Compliance and ethics
The author(s) declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Wu, C., Shang, H., Jiang, X. et al. Application of germ-free NOD-scid IL2rgnull mice as a humanized model for tumor microbiome precision medicine. Sci. China Life Sci. 64, 644–647 (2021). https://doi.org/10.1007/s11427-020-1876-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-020-1876-1